Medical Developments (Australia) Buy Hold or Sell Recommendation
| MVP Stock | 0.66 0.01 1.54% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Medical Developments International is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Medical Developments International given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Medical Developments International, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Medical Developments Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Medical and provide practical buy, sell, or hold advice based on investors' constraints. Medical Developments International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Medical |
Execute Medical Developments Buy or Sell Advice
The Medical recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medical Developments International. Macroaxis does not own or have any residual interests in Medical Developments International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medical Developments' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Medical Developments Trading Alerts and Improvement Suggestions
| Medical Developments is way too risky over 90 days horizon | |
| Medical Developments has some characteristics of a very speculative penny stock | |
| Medical Developments appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 33.15 M. Net Loss for the year was (40.99 M) with profit before overhead, payroll, taxes, and interest of 28.08 M. | |
| Medical Developments International has accumulated about 24.66 M in cash with (10.78 M) of positive cash flow from operations. | |
| Roughly 18.0% of the company outstanding shares are owned by corporate insiders |
Medical Developments Returns Distribution Density
The distribution of Medical Developments' historical returns is an attempt to chart the uncertainty of Medical Developments' future price movements. The chart of the probability distribution of Medical Developments daily returns describes the distribution of returns around its average expected value. We use Medical Developments International price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medical Developments returns is essential to provide solid investment advice for Medical Developments.
| Mean Return | 1.08 | Value At Risk | -7.5 | Potential Upside | 11.54 | Standard Deviation | 8.61 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medical Developments historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medical Developments Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medical Developments or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medical Developments' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medical stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.17 | |
β | Beta against Dow Jones | 0.94 | |
σ | Overall volatility | 8.61 | |
Ir | Information ratio | 0.14 |
Medical Developments Volatility Alert
Medical Developments International is displaying above-average volatility over the selected time horizon. Medical Developments International is a potential penny stock. Although Medical Developments may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Medical Developments International. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Medical instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Medical Developments Fundamentals Vs Peers
Comparing Medical Developments' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medical Developments' direct or indirect competition across all of the common fundamentals between Medical Developments and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medical Developments or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medical Developments' fundamental indicators could also be used in its relative valuation, which is a method of valuing Medical Developments by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medical Developments to competition |
| Fundamentals | Medical Developments | Peer Average |
| Return On Equity | -0.45 | -0.31 |
| Return On Asset | -0.0123 | -0.14 |
| Profit Margin | (0.78) % | (1.27) % |
| Operating Margin | 0.06 % | (5.51) % |
| Current Valuation | 58.88 M | 16.62 B |
| Shares Outstanding | 112.66 M | 571.82 M |
| Shares Owned By Insiders | 18.39 % | 10.09 % |
| Shares Owned By Institutions | 24.51 % | 39.21 % |
| Price To Book | 1.34 X | 9.51 X |
| Price To Sales | 1.95 X | 11.42 X |
| Revenue | 33.15 M | 9.43 B |
| Gross Profit | 28.08 M | 27.38 B |
| EBITDA | (29.45 M) | 3.9 B |
| Net Income | (40.99 M) | 570.98 M |
| Cash And Equivalents | 24.66 M | 2.7 B |
| Total Debt | 2.29 M | 5.32 B |
| Book Value Per Share | 0.49 X | 1.93 K |
| Cash Flow From Operations | (10.78 M) | 971.22 M |
| Earnings Per Share | (0.46) X | 3.12 X |
| Target Price | 3.5 | |
| Number Of Employees | 13 | 18.84 K |
| Beta | 1.71 | -0.15 |
| Market Capitalization | 74.35 M | 19.03 B |
| Total Asset | 59.16 M | 29.47 B |
| Retained Earnings | (62.86 M) | 9.33 B |
| Working Capital | 16.59 M | 1.48 B |
| Net Asset | 59.16 M |
Medical Developments Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medical . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Medical Developments Buy or Sell Advice
When is the right time to buy or sell Medical Developments International? Buying financial instruments such as Medical Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medical Developments in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Education Thematic Idea Now
Education
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.